You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HRR deficiency

Showing 1 - 25 of 3,467
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors, Homologous Recombination Repair Gene Mutation, Homologous Recombination Deficiency Trial in Korea, Republic of

Recruiting
  • Solid Tumors
  • +2 more
  • Goyang, Gyeongggi-do, Korea, Republic of
  • +17 more
Jan 20, 2022

Homologous Recombination-related Genesmutationsand HRD in Breast

Not yet recruiting
  • Breast Cancer
  • HER2-low Breast Cancer
  • Standard Management
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Jul 18, 2022

Breast Cancer Trial in Spain (Olaparib)

Terminated
  • Breast Cancer
  • Barcelona, Spain
  • +7 more
Jan 18, 2023

Pancreatic Acinar Cell Carcinoma Trial run by the National Cancer Institute (NCI) (Olaparib)

Recruiting
  • Pancreatic Acinar Cell Carcinoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Lung Cancer, Mesothelioma Trial in Orbassano (niraparib and dostarlimab)

Recruiting
  • Lung Cancer
  • Mesothelioma
  • niraparib and dostarlimab
  • Orbassano, Turin, Italy
    AOU San Luigi- Department of Oncology
Oct 6, 2021

Down Syndrome, Vitamin D Deficiency Trial in Taif (High intensity treamill exercise training., Moderate intensity treamill

Completed
  • Down Syndrome
  • Vitamin D Deficiency
  • High intensity treamill exercise training.
  • Moderate intensity treamill exercise training.
  • Taif, Mecca, Saudi Arabia
    College of applied medical sciences
Aug 30, 2021

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial (HS-10502)

Not yet recruiting
  • Ovarian Cancer
  • +4 more
  • (no location specified)
Feb 24, 2023

Mental Health Issue Trial in Haveli (25 hydroxy cholecalciferol (Vitamin D) /25(OH)D3., Placebo)

Not yet recruiting
  • Mental Health Issue
  • 25 hydroxy cholecalciferol (Vitamin D) /25(OH)D3.
  • Placebo
  • Haveli, Azad Jammu And Kashmir, Pakistan
    District Headquarter Hospital Haveli
Oct 24, 2023

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

A Study of Long-Term Responders on Olaparib

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
    • Randwick, New South Wales, Australia
    • +7 more
    Nov 30, 2021

    Ovarian Cancer, Breast Cancer, Solid Tumor Trial in Houston, Brisbane (CYH33)

    Recruiting
    • Ovarian Cancer
    • +4 more
    • New Haven, Connecticut
    • +6 more
    Oct 10, 2022

    Her-2 Negative Breast Cancer, HRR Gene Mutation Trial in Guangzhou (Camrelizumab, Fluzoparib, Nab-paclitaxel)

    Recruiting
    • Her-2 Negative Breast Cancer
    • HRR Gene Mutation
    • Guangzhou, Guangdong, China
      First Affiliated Hospital, Sun Yat-Sen University
    Mar 7, 2023

    Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body

    Recruiting
    • Sarcoma
    • +2 more
    • Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
    Oct 3, 2023

    Advanced Ovarian Cancer Trial in Spain (Olaparib, Pegylated Liposomal Doxorubicin)

    Completed
    • Advanced Ovarian Cancer
    • Sabadell, Barcelona, Spain
    • +7 more
    Jan 25, 2023

    Advanced Breast Cancer Trial in Seoul (Talazoparib Oral Capsule)

    Recruiting
    • Advanced Breast Cancer
    • Talazoparib Oral Capsule
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    May 14, 2021

    Metastatic Castrate Sensitive Prostate Cancer Trial in Worldwide (Niraparib, Abiraterone acetate (AA), Prednisone)

    Recruiting
    • Metastatic Castrate Sensitive Prostate Cancer
    • Homewood, Alabama
    • +439 more
    Jan 17, 2023

    Cancers With DNA Repair-Deficiency Trial in Germany (Olaparib, Physician's choice, Trabectedin)

    Recruiting
    • Cancers With DNA Repair-Deficiency
    • Dresden, Germany
    • +8 more
    Jan 12, 2022

    ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer, a Germline or Somatic BRCA Mutation, or a

    Recruiting
    • ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancer
    • a Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
    • Montpellier, France
    • +1 more
    Nov 16, 2022

    Metastatic Castration-resistant Prostate Cancer Trial (Niraparib plus Abiraterone Acetate (Nira/AA) combination,

    Available
    • Metastatic Castration-resistant Prostate Cancer
    • (no location specified)
    Aug 24, 2022

    HRR Prevalence in LatAm PROSPECT Study

    Completed
    • Castration-resistant Prostate Cancer
      • Ciudad Autónoma de Buenos Aires, Argentina
      • +10 more
      Apr 19, 2022

      HRR as a Novel Biomarker in Sjögren's Syndrome

      Completed
      • Sjögren's Syndrome
      • blood sample analysis
      • Tianjin, Tianjin, China
        Tianjin Eye Hospital
      Nov 30, 2022

      Iron Deficiency, Anaemia in Children Trial in Makassar (Elemental iron, Elemental iron and Vit D)

      Completed
      • Iron Deficiency, Anaemia in Children
      • Elemental iron
      • Elemental iron and Vit D
      • Makassar, Sulawesi Selatan, Indonesia
        Universitas Hasanuddin
      Nov 22, 2023

      Antithrombin III Deficiency Trial in Brussel (observation)

      Not yet recruiting
      • Antithrombin III Deficiency
      • observation
      • Brussel, Belgium
        UZ Brussel
      May 26, 2023

      mCRPC Trial in Australia, China, United States (Placebo, Senaparib)

      Not yet recruiting
      • mCRPC
      • Binghamton, New York
      • +5 more
      Dec 14, 2021

      End Stage Renal Disease Trial in Cambridge (Payment adjustment for home dialysis and transplant)

      Completed
      • End Stage Renal Disease
      • Payment adjustment for home dialysis and transplant
      • Cambridge, Massachusetts
        Massachusetts Institute of Technology
      Oct 31, 2022